Varex Imaging's Q1 revenue up 5%, slightly beats estimates

Reuters
02/11
<a href="https://laohu8.com/S/VREX">Varex Imaging</a>'s Q1 revenue up 5%, slightly beats estimates

Overview

  • X-ray imaging components maker's Q1 revenue rose 5% yr/yr, slightly beating analysts' expectations

  • Non-GAAP EPS increased to $0.19 from $0.10 in the prior year

  • Growth driven by 17% increase in Industrial segment revenue, led by cargo systems

Outlook

  • Company expects Q2 FY26 revenue between $210 mln and $225 mln

  • Varex anticipates strong demand for CT products and cargo security systems

  • Company forecasts Q2 FY26 non-GAAP EPS between $0.15 and $0.25

Result Drivers

  • CARGO SYSTEMS - Growth in the quarter was driven by strength in cargo systems business, contributing to a 17% year-over-year increase in Industrial segment revenue, said CEO Sunny Sanyal

  • INVENTORY IMPACT - Cash outflow from operations was driven by an increase in working capital, primarily due to inventory

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Slight Beat*

$209.60 mln

$207.69 mln (5 Analysts)

Q1 Net Income

$2.40 mln

Q1 Gross Margin

33.00%

Q1 Adjusted Operating Margin

9.00%

Q1 Operating Income

$15.40 mln

Q1 Pretax Profit

$3.80 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

  • Wall Street's median 12-month price target for Varex Imaging Corp is $18.00, about 28.2% above its February 9 closing price of $14.04

  • The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 15 three months ago

Press Release: ID:nBwbC47Lfa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10